Case Report

Refractory Diffuse Bony Pain 20 Years After Jejunoileal Bypass

Authors: Chih-Chien Sung, MD, Herng-Sheng Lee, MD, PhD, Liang-Kuang Diang, MD, Shih-Hua Lin, MD

Abstract

Osteomalacia can be a late but unrecognized complication following jejunoileal bypass. We describe a 53-year-old man who underwent jejunoileal bypass for morbid obesity twenty years earlier who suffered from progressive diffuse bony pain refractory to nonsteroidal anti-inflammatory drugs. He was initially diagnosed with a malignancy with bone metastasis. However, pertinent laboratory data were notable for hypocalcemia (7.5 mg/dL, albumin 4.1 mg/dL) with low urinary calcium excretion (14 mg/day), hypophosphatemia (2.0 mg/dL) with low urinary phosphate excretion (53 mg/day), hypomagnesemia (1.5 mg/dL) with low urine magnesium excretion (23 mg/day), low 1, 25 (OH)2 vitamin D3, and elevated serum alkaline phosphatase and intact parathyroid hormone (iPTH). These laboratory findings pointed to a defect in calcium, phosphate, and magnesium handling in the gastrointestinal tract. Bone biopsy of the iliac crest clearly demonstrated typical changes of osteomalacia with excessive osteoid accumulation and reduced mineralization. His clinical symptoms were refractory to oral 1, 25 (OH)2 vitamin D3 and calcium supplementation but significantly improved with the addition of intermittent intravenous active 1, 25 (OH)2 vitamin D3, calcium, phosphate, and magnesium supplementation. Osteomalacia is an easily misdiagnosed late complication of jejunoileal bypass. Early recognition can avoid circuitous diagnosis and inappropriate management.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1.Hocking MP, Duerson MC, O'Leary JP, et al. Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases. N Engl J Med 1983;308:995–999.
 
2.Sellin JH, Meredith SC, Kelly S, et al. Prospective evaluation of metabolic bone disease after jejunoileal bypass. Gastroenterology 1984;87:123–129.
 
3.Hocking MP, Davis GL, Franzini DA, et al. Long-term consequences after jejunoileal bypass for morbid obesity. Dig Dis Sci 1998;43:2493–2499.
 
4.Bikle DD. Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res 2007;22(suppl 2):V50–V54.
 
5.Compston JE, Horton LW, Laker MF, et al. Bone disease after jejuno-ileal bypass for obesity. Lancet 1978;2:1–4.
 
6.Jørgensen S, Olesen M, Gudman-Høyer E. A review of 20 years of jejunoileal bypass. Scand J Gastroenterol 1997;32:334–339.
 
7.Haria DM, Sibonga JD, Taylor HC. Hypocalcemia, hypovitaminosis D osteopathy, osteopenia, and secondary hyperparathyroidism 32 years after jejunoileal bypass. Endocr Pract 2005;11:335–340.
 
8.Williams SE, Seidner DL. Metabolic bone disease in gastrointestinal illness. Gastroenterol Clin North Am 2007;36:161–190, viii.
 
9.Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–281.
 
10.Honasoge M, Rao DS. Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders and total parenteral nutrition. Curr Opin Rheumatol 1995;7:249–254.
 
11.Bertoli A, Di Daniele N, Troisi A, et al. A woman with bone pain, fractures, and malabsorption. Lancet 1996;347:300.
 
12.Demay MB, Rosenthal DI, Deshpande V. Case records of the Massachusetts General Hospital. Case 16–2008. A 46-year-old woman with bone pain. N Engl J Med 2008;358:2266–2274.
 
13.Basha B, Rao DS, Han ZH, et al. Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. Am J Med 2000;108:296–300.
 
14.Mosekilde L, Melsen F, Hessov I, et al. Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity. Gut 1980;21:624–631.
 
15.Compston JE, Ayers AB, Horton LW, et al. Osteomalacia after small-intestinal resection. Lancet 1978;1:9–12.
 
16.Compston JE, Horton LW, Laker MF, et al. Treatment of bone disease after jejunoileal bypass for obesity with oral 1 alpha-hydroxyvitamin D3. Gut 1980;21:669–674.
 
17.Amanzadeh J, Reilly RF Jr. Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol 2006;2:136–148.